Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 36 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 18 |
NetGPI | no | yes: 0, no: 18 |
Term | Name | Level | Count |
---|---|---|---|
GO:0016020 | membrane | 2 | 19 |
GO:0110165 | cellular anatomical entity | 1 | 19 |
Related structures:
AlphaFold database: A4HL21
Term | Name | Level | Count |
---|---|---|---|
GO:0006810 | transport | 3 | 19 |
GO:0016192 | vesicle-mediated transport | 4 | 19 |
GO:0051179 | localization | 1 | 19 |
GO:0051234 | establishment of localization | 2 | 19 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 32 | 34 | PF00675 | 0.374 |
CLV_PCSK_KEX2_1 | 34 | 36 | PF00082 | 0.351 |
CLV_PCSK_KEX2_1 | 5 | 7 | PF00082 | 0.431 |
CLV_PCSK_PC1ET2_1 | 34 | 36 | PF00082 | 0.374 |
CLV_PCSK_PC1ET2_1 | 5 | 7 | PF00082 | 0.431 |
CLV_PCSK_SKI1_1 | 143 | 147 | PF00082 | 0.486 |
CLV_PCSK_SKI1_1 | 35 | 39 | PF00082 | 0.273 |
CLV_PCSK_SKI1_1 | 5 | 9 | PF00082 | 0.395 |
DEG_APCC_DBOX_1 | 120 | 128 | PF00400 | 0.194 |
DEG_APCC_DBOX_1 | 34 | 42 | PF00400 | 0.557 |
DOC_CDC14_PxL_1 | 15 | 23 | PF14671 | 0.639 |
DOC_CYCLIN_RxL_1 | 140 | 150 | PF00134 | 0.322 |
DOC_CYCLIN_RxL_1 | 88 | 96 | PF00134 | 0.383 |
DOC_CYCLIN_yCln2_LP_2 | 172 | 178 | PF00134 | 0.194 |
DOC_MAPK_gen_1 | 33 | 39 | PF00069 | 0.586 |
DOC_PP1_RVXF_1 | 10 | 16 | PF00149 | 0.615 |
DOC_PP1_RVXF_1 | 33 | 40 | PF00149 | 0.440 |
DOC_PP2B_LxvP_1 | 172 | 175 | PF13499 | 0.194 |
DOC_USP7_MATH_1 | 105 | 109 | PF00917 | 0.490 |
LIG_14-3-3_CanoR_1 | 33 | 38 | PF00244 | 0.499 |
LIG_14-3-3_CanoR_1 | 6 | 13 | PF00244 | 0.684 |
LIG_14-3-3_CanoR_1 | 88 | 94 | PF00244 | 0.480 |
LIG_BIR_II_1 | 1 | 5 | PF00653 | 0.680 |
LIG_BRCT_BRCA1_1 | 35 | 39 | PF00533 | 0.480 |
LIG_FHA_1 | 2 | 8 | PF00498 | 0.577 |
LIG_FHA_1 | 43 | 49 | PF00498 | 0.304 |
LIG_FHA_2 | 27 | 33 | PF00498 | 0.589 |
LIG_FHA_2 | 78 | 84 | PF00498 | 0.194 |
LIG_LIR_Gen_1 | 120 | 131 | PF02991 | 0.418 |
LIG_LIR_Gen_1 | 36 | 47 | PF02991 | 0.471 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.398 |
LIG_LIR_Nem_3 | 132 | 138 | PF02991 | 0.338 |
LIG_LIR_Nem_3 | 150 | 156 | PF02991 | 0.284 |
LIG_LIR_Nem_3 | 36 | 42 | PF02991 | 0.495 |
LIG_LIR_Nem_3 | 45 | 49 | PF02991 | 0.336 |
LIG_OCRL_FandH_1 | 38 | 50 | PF00620 | 0.438 |
LIG_Pex14_1 | 61 | 65 | PF04695 | 0.357 |
LIG_Pex14_2 | 11 | 15 | PF04695 | 0.550 |
LIG_SH2_CRK | 169 | 173 | PF00017 | 0.360 |
LIG_SH2_STAP1 | 135 | 139 | PF00017 | 0.355 |
LIG_SH2_STAP1 | 85 | 89 | PF00017 | 0.515 |
LIG_SH2_STAT3 | 138 | 141 | PF00017 | 0.302 |
LIG_SH2_STAT5 | 138 | 141 | PF00017 | 0.341 |
LIG_SH2_STAT5 | 180 | 183 | PF00017 | 0.359 |
LIG_SH3_3 | 95 | 101 | PF00018 | 0.480 |
LIG_SUMO_SIM_anti_2 | 122 | 128 | PF11976 | 0.237 |
LIG_SUMO_SIM_anti_2 | 45 | 51 | PF11976 | 0.320 |
LIG_SUMO_SIM_par_1 | 100 | 106 | PF11976 | 0.494 |
LIG_SUMO_SIM_par_1 | 18 | 24 | PF11976 | 0.614 |
LIG_TYR_ITIM | 167 | 172 | PF00017 | 0.256 |
MOD_CK1_1 | 26 | 32 | PF00069 | 0.596 |
MOD_CK2_1 | 26 | 32 | PF00069 | 0.563 |
MOD_CK2_1 | 77 | 83 | PF00069 | 0.458 |
MOD_GlcNHglycan | 29 | 32 | PF01048 | 0.410 |
MOD_GSK3_1 | 1 | 8 | PF00069 | 0.569 |
MOD_GSK3_1 | 181 | 188 | PF00069 | 0.429 |
MOD_GSK3_1 | 23 | 30 | PF00069 | 0.565 |
MOD_N-GLC_1 | 89 | 94 | PF02516 | 0.183 |
MOD_NEK2_1 | 1 | 6 | PF00069 | 0.589 |
MOD_NEK2_1 | 119 | 124 | PF00069 | 0.358 |
MOD_NEK2_1 | 181 | 186 | PF00069 | 0.365 |
MOD_NEK2_1 | 42 | 47 | PF00069 | 0.325 |
MOD_NEK2_1 | 77 | 82 | PF00069 | 0.399 |
MOD_NEK2_2 | 105 | 110 | PF00069 | 0.418 |
MOD_PK_1 | 33 | 39 | PF00069 | 0.443 |
MOD_PKA_1 | 33 | 39 | PF00069 | 0.577 |
MOD_PKA_1 | 5 | 11 | PF00069 | 0.505 |
MOD_PKA_2 | 5 | 11 | PF00069 | 0.680 |
MOD_Plk_1 | 105 | 111 | PF00069 | 0.385 |
MOD_Plk_1 | 89 | 95 | PF00069 | 0.514 |
MOD_Plk_4 | 148 | 154 | PF00069 | 0.276 |
MOD_Plk_4 | 42 | 48 | PF00069 | 0.365 |
MOD_Plk_4 | 57 | 63 | PF00069 | 0.270 |
MOD_Plk_4 | 77 | 83 | PF00069 | 0.297 |
MOD_SUMO_rev_2 | 26 | 36 | PF00179 | 0.600 |
TRG_DiLeu_BaLyEn_6 | 98 | 103 | PF01217 | 0.537 |
TRG_ENDOCYTIC_2 | 169 | 172 | PF00928 | 0.287 |
TRG_ENDOCYTIC_2 | 180 | 183 | PF00928 | 0.303 |
TRG_ER_diArg_1 | 164 | 167 | PF00400 | 0.238 |
TRG_Pf-PMV_PEXEL_1 | 143 | 148 | PF00026 | 0.574 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N0P3W0 | Leptomonas seymouri | 62% | 99% |
A0A0N1HVI2 | Leptomonas seymouri | 27% | 100% |
A0A0S4IRN3 | Bodo saltans | 23% | 86% |
A0A1X0P478 | Trypanosomatidae | 43% | 99% |
A0A3Q8IH86 | Leishmania donovani | 70% | 100% |
A0A3Q8IHH3 | Leishmania donovani | 25% | 100% |
A0A3R7KL43 | Trypanosoma rangeli | 44% | 99% |
A0A3R7KRD8 | Trypanosoma rangeli | 23% | 100% |
A4HL20 | Leishmania braziliensis | 26% | 100% |
A4I8K1 | Leishmania infantum | 25% | 100% |
A4I8K2 | Leishmania infantum | 70% | 100% |
D0AAL6 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 22% | 100% |
E9B3G1 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 25% | 100% |
E9B3G2 | Leishmania mexicana (strain MHOM/GT/2001/U1103) | 68% | 100% |
Q4Q4N8 | Leishmania major | 68% | 100% |
Q4Q4N9 | Leishmania major | 25% | 100% |
V5BLE0 | Trypanosoma cruzi | 23% | 100% |